The Skindex instruments to measure the effects of skin disease on quality of life.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 3269028)

Published in Dermatol Clin on December 20, 2011

Authors

Mary-Margaret Chren1

Author Affiliations

1: Department of Dermatology, University of California at San Francisco, San Francisco, CA 94143–0808, USA. chrenm@derm.ucsf.edu

Associated clinical trials:

Qbrexza Cloths for Hyperhidrosis of Amputation Sites | NCT04924036

Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus (VULVIE) | NCT04951206

Articles citing this

The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause (2013) 1.70

Impact of acne on quality of life of students at sultan qaboos university. Oman Med J (2015) 0.81

A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer (2015) 0.78

Dysgeusia and weight loss under treatment with vismodegib: benefit of nutritional management. Support Care Cancer (2015) 0.78

Dermatologic events from EGFR inhibitors: the issue of the missing patient voice. Support Care Cancer (2016) 0.75

The Impact of Inflammatory and Infectious Diseases of Vulvar on Quality of Life. J Menopausal Med (2016) 0.75

Responsiveness of the Spanish Version of the "Skin Cancer Index". J Skin Cancer (2016) 0.75

Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional Study. J Clin Med (2015) 0.75

Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis (2017) 0.75

Comparing the Quality of Ambulatory Surgical Care for Skin Cancer in a Veterans Affairs Clinic and a Fee-For-Service Practice Using Clinical and Patient-Reported Measures. PLoS One (2017) 0.75

Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study. Clin Cosmet Investig Dermatol (2016) 0.75

The Association between Atopic Disorders and Keloids: A Case-control Study. Indian J Dermatol (2015) 0.75

Articles cited by this

Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol (1994) 10.17

A methodological framework for assessing health indices. J Chronic Dis (1985) 9.76

Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol (2010) 3.09

Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol (1997) 2.83

Interpretation of quality-of-life scores. J Invest Dermatol (2010) 2.52

Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol (1996) 2.26

Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg (2001) 2.10

The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol (2002) 1.84

Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol (2007) 1.73

Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol (2007) 1.52

Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol (1998) 1.49

Psoriasis--an index of disability. Clin Exp Dermatol (1987) 1.28

Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol (2009) 1.09

Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol (2006) 0.99

Categorization of Skindex-29 scores using mixture analysis. Dermatology (2008) 0.99

Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol (2011) 0.98

Measurement of vital signs for skin diseases. J Invest Dermatol (2005) 0.96

The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol (2002) 0.96

Effects of vulvodynia on quality of life. J Am Acad Dermatol (2008) 0.95

The Spanish version of Skindex-29. Int J Dermatol (2000) 0.95

NailQoL: a quality-of-life instrument for onychomycosis. Int J Dermatol (2007) 0.92

Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol (2008) 0.90

Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Br J Dermatol (2008) 0.89

Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy (2009) 0.89

Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol (2002) 0.87

Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial. J Eur Acad Dermatol Venereol (2009) 0.86

The venous leg ulcer quality of life (VLU-QoL) questionnaire: development and psychometric validation. Wound Repair Regen (2007) 0.85

Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol (2010) 0.81

A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting. Br J Dermatol (2007) 0.79

Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem. J Dermatol (2010) 0.78

Baseline quality of life as measured by Skindex-16+5 in patients presenting to a referral center for patch testing. Dermatitis (2009) 0.78